Gold nanoparticles conjugated with epidermal growth factor and gadolinium for precision delivery of contrast agents in magnetic resonance imaging
dc.contributor.author | Queiroz, Marinho de | |
dc.contributor.author | Veriato, Thaís da Silva | |
dc.contributor.author | Raniero, Leandro José | |
dc.contributor.author | Castilho, Maiara Lima | |
dc.date.accessioned | 2025-03-11T23:30:27Z | |
dc.date.available | 2025-03-11T23:30:27Z | |
dc.date.issued2 | 2024-03 | |
dc.description.abstract | The utilization of contrast agents in magnetic resonance imaging (MRI) has become increasingly important in clinical diagnosis. However, the low diagnostic specificity of this technique is a limiting factor for the early detection of tumors. To develop a new contrast agent with a specific target for early stage tumors, we present the synthesis and characterization of a nanocontrast composed of gold nanoparticles (AuNPs), gadopentetic acid (Gd-DTPA), and epidermal growth factor (EGF). Carbodiimide-based chemistry was utilized to modify Gd-DTPA for functionalization with AuNPs. This resulted in the formation of the Au@Gd-EGF nanocontrast. The relaxation rate (1/T1) of the nanocontrast was analyzed using MRI, and cytotoxicity was determined based on cell viability and mitochondrial activity in a human breast adenocarcinoma cell line. Fourier-transform infrared spectroscopy analysis confirmed the effectiveness of carbodiimide in the formation of the Gd-DTPA-cysteamine complex in the presence of bands at 930, 1042, 1232, 1588, and 1716 cm-1. The complexes exhibited good interactions with the AuNPs. However, the signal intensity of the Au@Gd-EGF nanocontrast was lower than that of the commercial contrast agent because the r1/r2 relaxivities of the Gd-DTPA-based contrast agents were lower than those of the gadoversetamide-based molecules. The Au@Gd-EGF nanocontrast agent exhibited good biocompatibility, low cytotoxicity, and high signal intensity in MRI with active targeted delivery, suggesting significant potential for future applications in the early diagnosis of tumors. | |
dc.description.physical | 12 f. | |
dc.description.sponsorship | Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP) | |
dc.description.sponsorship | Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES) | |
dc.description.uri | FAPESP (Project 2018/23898-6), CNPq (Project 427602/2018-1 and 302994/2018-4) | |
dc.format.mimetype | ||
dc.identifier.affiliation | Universidade do Vale do Paraíba | |
dc.identifier.affiliation | Universidade do Vale do Paraíba | |
dc.identifier.affiliation | Universidade do Vale do Paraíba | |
dc.identifier.affiliation | Universidade do Vale do Paraíba | |
dc.identifier.bibliographicCitation | QUEIROZ, M. de et al. Gold nanoparticles conjugated with epidermal growth factor and gadolinium for precision delivery of contrast agents in magnetic resonance imaging. Radiological Physics and Technology, [S. l.], v. 17, n. 1, p. 153–164, mar. 2024. Disponível em: https://link.springer.com/article/10.1007/s12194-023-00761-y | |
dc.identifier.doi | 10.1007/s12194-023-00761-y | |
dc.identifier.uri | https://repositorio.univap.br/handle/123456789/682 | |
dc.language.iso | en_US | |
dc.publisher | Springer-Verlag London Ltd. | |
dc.rights.holder | Maiara Lima Castilho | |
dc.rights.holder | Japanese Society of Radiological Technology and Japan Society of Medical Physics | |
dc.subject.keyword | Gold nanoparticle | |
dc.subject.keyword | Magnetic resonance imaging | |
dc.subject.keyword | Epidermal growth factor | |
dc.subject.keyword | Gadopentetic acid | |
dc.title | Gold nanoparticles conjugated with epidermal growth factor and gadolinium for precision delivery of contrast agents in magnetic resonance imaging | |
dc.type | Artigos de Periódicos |
Arquivos
Pacote Original
1 - 1 de 1
Carregando...
- Nome:
- s12194-023-00761-y.pdf
- Tamanho:
- 2.81 MB
- Formato:
- Adobe Portable Document Format
- Descrição:
- Acesso via Portal de Periódicos Capes
Licença do Pacote
1 - 1 de 1
Nenhuma Miniatura disponível
- Nome:
- license.txt
- Tamanho:
- 1.71 KB
- Formato:
- Item-specific license agreed upon to submission
- Descrição: